Biotech and Scrum: Rethinking How Biotech Innovates in the 21st Century

Scrum is commonplace in the software industry, but its ideas and principles can be applied to other domains and contexts. Can the ideas of Scrum help Biotech firms deliver more value, whilst navigating the complexities of innovation? Can Scrum work in an environment where experiments take time, failure is likely, partnerships are proliferating, and roles are highly specialized?

And will scientists actually accept this new way of working?

In this webinar Dave West CEO of Scrum.org talks to Tyson Bertmaring, MBA, Head of Partner Success at Dyno Therapeutics, and Matt Abbinanti, Ph.D., Senior Program Manager at CRISPR Therapeutics on how Scrum master course in Chennai works in Biotech. Professional Agile Leadership Essentials is a 2 day workshop to equip leaders and managers of Agile teams along with their Product Owners and Scrum Masters to help their organizations change by providing participants with: An overview of what "Agile" is and why organizations need it to thrive in a changing world. The means to identify the potential opportunities, challenges and impacts of Agile in terms of business value and why this is so important to the next generation organization. An understanding of techniques to support teams to sustain long-term agility including the role that leaders play, shifts in thinking, and the relationship between complexity and empiricism. Ways to continue the development of the people to help them grow and prosper in an agile way of working. Guidance of how to measure and guide agile product delivery. Discuss ways to scale agility across several teams within the organization while keeping them working together to deliver on a common vision.

About Our Speakers

Matt Abbinanti, Ph.D., Senior Program Manager at CRISPR Therapeutics

After a postdoc studying the electrophysiological changes in spinal neurons after spinal cord injury, Matt entered the biotech industry as a scientist for BioAxone Biosciences. Later, as Director of Research and Project Management at BioAxone, he was responsible for leading the preclinical development of small-molecule Rho kinase inhibitors from discovery stage through IND-enabling studies for the treatment of cavernous angioma, neurotrauma, and glaucoma. He made the transition to Program Management at CRISPR Therapeutics in early 2019, facilitating the installation of the Scrum framework for a high-performing research team and managing multiple alliances and research-stage programs.

Tyson Bertmaring, MBA, Head of Partner Success at Dyno Therapeutics

Tyson Bertmaring began his career as a United States Air Force officer leading teams across diverse environments, spanning from nuclear deterrence to R&D. Since departing active duty, Tyson has transitioned those experiences to serve R&D teams across both large and small biotech companies and alliances. He is passionate about experimenting with Scrum to realize the joy and achievement of others through fulfilling teamwork. Tyson’s current experiment is enterprise wide at Dyno Therapeutics, a biotech startup.

Dave West, CEO, Scrum.org

Dave is the CEO at Scrum.org. He is a frequent keynote at major industry conferences and is a widely published author of articles and research reports, along with his acclaimed book: Head First Object-Oriented Analysis and Design, that helped define new software modeling and application development processes. He led the development of the Rational Unified Process (RUP) for IBM/Rational. After IBM/Rational, West returned to consulting and managed Ivar Jacobson Consulting for North America. Then as VP, research director Forrester research where he ran the software development and delivery practice. Prior to joining Scrum.org he was Chief Product Officer at Tasktop where he was responsible for product management, engineering and architecture.

Resource: https://www.scrum.org/resources/biotech-and-scrum-rethinking-how-biotech-innovates-21st-century